UNITED STATES
SECURITY AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant x Filed by a Party other than the Registrant ¨
Check the appropriate box:
| ¨ |
Preliminary Proxy Statement | |
| ¨ |
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)). | |
| ¨ |
Definitive Proxy Statement | |
| x |
Definitive Additional Materials | |
| ¨ |
Soliciting Material Pursuant to Section 240.14a-12 | |
ENDO HEALTH SOLUTIONS INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
| x |
No fee required | |||
| ¨ |
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. | |||
| (1) |
Title of each class of securities to which transaction applies
| |||
| (2) |
Aggregate number of securities to which transaction applies
| |||
| (3) |
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined)
| |||
| (4) |
Proposed maximum aggregate value of transaction
| |||
| (5) |
Total fee paid | |||
|
| ||||
| ¨ |
Fee paid previously with preliminary materials. | |||
| ¨ |
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. | |||
| (1) |
Amount Previously Paid
| |||
| (2) |
Form, Schedule or Registration Statement No.
| |||
| (3) |
Filing Party
| |||
| (4) |
Date Filed
| |||
*** Exercise Your Right to Vote ***
Important Notice Regarding the Availability of Proxy Materials for the
Shareholder Meeting to Be Held on May 22, 2013.
|
ENDO HEALTH SOLUTIONS INC.
|
Meeting Information
|
|||||||
| Meeting Type: Annual Meeting |
||||||||
| For holders as of: April 1, 2013 |
||||||||
| Date: May 22, 2013 Time: 10:00 AM |
||||||||
| Location: Corporate Headquarters |
||||||||
| 1400 Atwater Drive |
||||||||
| Malvern, PA 19355
For directions, please visit our company website at http://www.endo.com/about-us/locations and follow directions for “Endo Corporate Headquarters”.
|
||||||||
|
|
ENDO HEALTH SOLUTIONS INC. 1400 ATWATER DRIVE MALVERN, PA 19355 ATTN: CAROLINE MANOGUE
|
You are receiving this communication because you hold shares in the company named above.
This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side).
We encourage you to access and review all of the important information contained in the proxy materials before voting.
| ||||||
| See the reverse side of this notice to obtain proxy materials and voting instructions. | ||||||||
— Before You Vote —
How to Access the Proxy Materials
|
Proxy Materials Available to VIEW or RECEIVE: |
||||||
|
NOTICE AND PROXY STATEMENT ANNUAL REPORT FORM 10-K |
||||||
|
How to View Online: |
||||||
|
Have the information that is printed in the box
marked by the arrow
|
||||||
|
How to Request and Receive a PAPER or E-MAIL Copy: |
||||||
|
If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request: |
||||||
|
1) BY INTERNET: www.proxyvote.com |
||||||
|
2) BY TELEPHONE: 1-800-579-1639 |
||||||
|
3) BY E-MAIL*: sendmaterial@proxyvote.com |
||||||
|
* If requesting materials by e-mail, please send a blank e-mail with the information that
is printed in the box marked by the arrow
|
||||||
|
Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before May 8, 2013 to facilitate timely delivery.
|
||||||
(located on the following page) and visit: www.proxyvote.com.— How To Vote —
Please Choose One of the Following Voting Methods
|
|
Vote In Person: Many shareholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares. |
|||||
|
Vote By Internet: To vote
now by internet, go to www.proxyvote.com. Have the information that is printed in the box marked by the arrow
|
||||||
|
Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.
|
||||||
| Voting Items | ||||||||||||||||||||
|
The Board of Directors recommends you vote “FOR” election of all of the following Directors to serve until the next Annual Meeting of Stockholders or until their successors are duly elected and qualified: |
||||||||||||||||||||
|
1. |
Election of Directors |
The Board of Directors recommends you vote “FOR” the following proposals:
2. To ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2013.
3. To approve, by advisory vote, named executive officer compensation. |
||||||||||||||||||
|
Nominees: |
||||||||||||||||||||
|
1a. |
Roger H. Kimmel |
|||||||||||||||||||
|
1b. |
Rajiv De Silva |
|||||||||||||||||||
|
1c. |
John J. Delucca |
|||||||||||||||||||
|
1d. |
Nancy J. Hutson, Ph.D. |
|||||||||||||||||||
|
1e. |
Michael Hyatt |
|||||||||||||||||||
|
1f. |
William P. Montague |
|||||||||||||||||||
|
1g. |
David B. Nash, M.D., M.B.A. |
|||||||||||||||||||
|
1h. |
Joseph C. Scodari |
|||||||||||||||||||
|
1i. |
Jill D. Smith |
|||||||||||||||||||
|
1j. |
William F. Spengler |
|||||||||||||||||||
|
|
||||||||||||||||||||
|
|
||||||
|
|
||||||
|
||||||